Iqvia Holdings Inc.
A health-intelligence giant that helps drugmakers run clinical trials, sell their medicines, and make sense of huge piles of healthcare data—drawing on a trove covering roughly nine in ten of the world's pharmaceuticals. It was born in 2016 when Quintiles, the contract-research firm founded by a statistics professor in 1982, merged with IMS Health, a market-data company from 1954. Its name blends letters from both: the "I" from IMS and "Q" from Quintiles, plus "VIA" for the road ahead.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 13GPassive | 7.49% | 12.71M | Apr 30, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 27, 2026 |
| HARRIS ASSOCIATES L P | 13G/APassive | 6.8% | 11.75M | Aug 14, 2025 |
| Harris Associates, Inc. | 13G/APassive | 6.8% | 11.75M | Aug 14, 2025 |
| GIC Private Ltd | 13G/APassive | 3.71% | 6.54M | May 9, 2025 |